All this evidence has supported the view that the severity and manifestation of intestinal disease in CF is dependent on the influence of modifier genes, that is to say on the existence of other genes that can modify the course of the disease independently of the type of mutation affecting the CFTR gene17–20. This evidence concerns the gene CFTR and cystic fibrosis.